P3I
TWST icon

Progeny 3 Inc’s Twist Bioscience TWST Stock Holding History

Progeny 3 Inc’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-188,282
Closed -$5.76M – 33
2020
Q1 		$5.76M Hold
188,282
– – 2.43% 10
2019
Q4 		$3.95M Hold
188,282
– – 3.6% 7
2019
Q3 		$4.5M Hold
188,282
– – 4.54% 7
2019
Q2 		$5.46M Buy
+188,282
New +$4.98M 5.74% 7

Other funds holding TWST

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Progeny 3 Inc's TWST Position: Q2 2020 in Review

Progeny 3 Inc sold out of Twist Bioscience (TWST) in Q2 2020, closing a stake of 188,282 shares — an estimated $5.76M sold.

Progeny 3 Inc first reported a position in TWST in Q2 2019 and held it in 4 quarters. The position peaked at $5.76M in Q1 2020. 146 funds tracked by Wall St. Rank hold TWST as of Q2 2020.

  • Progeny 3 Inc reported no remaining Twist Bioscience position as of Q2 2020 after selling out during the quarter.
  • Progeny 3 Inc sold 188,282 Twist Bioscience shares in Q2 2020, an estimated $5.76M.
  • Progeny 3 Inc first reported a position in Twist Bioscience in Q2 2019 and held it in 4 quarters.
  • Progeny 3 Inc's Twist Bioscience position peaked at $5.76M in Q1 2020.
  • 146 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2020.

Based on Progeny 3 Inc's 13F filing for Q2 2020, filed 14 Aug 2020.